Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging…
VANCOUVER, BC, Sept. 18, 2025 /PRNewswire/ -- USA News Group News Commentary –Today, Americans over 65 command $22,356 in annual healthcare spending per person versus just $4,217 for children[1], driving unprecedented investment in longevity solutions as populations worldwide confront global demographics where those aged 60+ will surge from 900 million in 2015 to 2 billion by 2050[2]. These macro forces position Avant Technologies, Inc. (OTCQB: AVAI), HCW Biologics Inc. (NASDAQ: HCWB), Solid…
PR Newswire
18/09/2025
From Geneva to Tokyo: World Meditation League Launches Quantified Meditation…
A New Era of Quantified MeditationAt the heart of the Challenge is the QM3™ format (Quantified Meditation 3) – a pioneering method that scientifically identifies the precise peak of meditation performance. Using advanced brain imaging and EEG-driven Brain-Computer Interface (BCI) technology, QM3 captures the deepest three minutes of inner silence, bridging neuroscience with centuries of contemplative tradition. A New Era of Quantified MeditationAt the heart of the Challenge is the QM3™...
PR Newswire
18/09/2025
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for…
The report said: "Major Trends in the Cell Therapy Market Are: Demand for Regenerative Medicine: Patients with untreated illnesses and disorders are rapidly shifting toward regenerative medicine due to its ability to restore the functions of tissues or organs lost due to disease and injuries. Regenerative therapies can be tailored to individual patient needs. This personalization further improves treatment outcomes; Rising Prevalence of Chronic Diseases: The prevalence of chronic diseases…
PR Newswire
18/09/2025
Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution…
Biogen to drive end-to-end development and commercialization of ThecaFlex DRx™, an investigational implantable device for intrathecal delivery of antisense oligonucleotides (ASOs)ThecaFlex DRx™ has the potential to be a new, convenient way to administer medicines to patients living with neurological disorders. CAMBRIDGE, Mass., Sept.18, 2025(GLOBE NEWSWIRE) --BiogenInc. (Nasdaq: BIIB) announced the company has entered into a definitive agreement to acquire Massachusetts-based...
Nasdaq GlobeNewswire
18/09/2025
From Dubai's Historic Gold Souk to Vogue Covers - La Marquise Redefines Luxury…
At the 2025 Cannes Film Festival, La Marquise made headlines for the third consecutive year, with more than 40 influential personalities, including acclaimed actresses and models, gracing the red carpet in signature pieces from its high jewellery collections. The brand's presence was highlighted in multiple prestigious publications, including Vogue Singapore, Harper's Bazaar, and Mojeh Magazine. At the 2025 Cannes Film Festival, La Marquise made headlines for the third consecutive year, with...
PR Newswire
18/09/2025
Reju Debuts AR Experience at Climate Week NYC, Showing the Problem of the Global…
Throughout Climate Week, New Yorkers will encounter QR code signage at high-traffic locations and near key Climate Week venues. Scanning the code leads users to an interactive microsite, where they can point their phone's camera at the two landmark buildings to activate Reju's AR filter. Throughout Climate Week, New Yorkers will encounter QR code signage at high-traffic locations and near key Climate Week venues. Scanning the code leads users to an interactive microsite, where they can point...
PR Newswire
18/09/2025
Medical Device Contract Manufacturing Market Size to Reach US$ 190.88 Billion by…
It also lets OEMs focus on R&D while partners handle molding, assembly, sterilization, and compliance, accelerating market readiness for devices like wearable biosensors and IoT-enabled tools. With robotics and digital twins boosting productivity by up to 25%, contract manufacturing goes beyond cost savings to expand healthcare access worldwide. It also lets OEMs focus on R&D while partners handle molding, assembly, sterilization, and compliance, accelerating market readiness for…
PR Newswire
18/09/2025
Ventilators Market Poised to Surpass USD 7.42 Billion by 2030, Says Mordor…
Mechanical Ventilators Leading the Way Mechanical Ventilators Leading the Way Mechanical ventilators, which form the core of advanced respiratory support, continue to represent the largest share within the ventilators market. The mechanical ventilators market sizeis estimated atUSD 5.33 billionin 2025 and is projected to surpassUSD 6.79 billionby 2030, reflecting a CAGR of 4.95% over the forecast period. Their demand is increasing as healthcare systems adapt to higher incidences...
PR Newswire
18/09/2025
First-Ever Multicenter Study of Hypothermic Oxygenated Perfusion (HOPE) with…
Conducted across five European pediatric liver transplant centers, results demonstrated that HOPE improves graft preservation by reducing reliance on static cold storage (liver preservation on ice alone) and mitigating ischemia-reperfusion injury, a serious complication that can compromise graft function. Importantly, the authors concluded that HOPE is safe in pediatric liver transplantation and is particularly beneficial for grafts with prolonged ischemia, including those from Donation after…
PR Newswire
18/09/2025
AI in Remote Patient Monitoring Market Projected to Reach US$ 10.35 Billion by…
North America leads the smart medical devices market with over 40% revenue share in 2024, supported by advanced healthcare systems and major players like Abbott and Medtronic. Asia-Pacific is the fastest-growing region with a CAGR of around 12%, driven by rising chronic diseases, digital health adoption, and healthcare investments in China and India. Europe remains stable, benefiting from strong regulations and digital health integration. The increasing demand for home care and AI-based…
PR Newswire
18/09/2025
MEDIPEEL Expands Across Europe After Strong CIS Performance, Reinforces Global…
Throughout this process, ES International has acted as MEDIPEEL's CIS distributor, overseeing reliable distribution and export operations, while contributing significantly to the brand's ability to build sustainable growth in the market. Throughout this process, ES International has acted as MEDIPEEL's CIS distributor, overseeing reliable distribution and export operations, while contributing significantly to the brand's ability to build sustainable growth in the market. MEDIPEEL's momentum...
PR Newswire
18/09/2025
Novo Nordisk A/S: Ozempic® reduces the risk of heart attack, stroke and death by…
Ozempic ®(once-weekly injectable semaglutide) was associated with a 23% reduced risk of heart attack, stroke and death in people with type 2 diabetes and cardiovascular disease on Medicare versus dulaglutide 1 Data also highlighted Ozempic ®was associated with a 26% lower risk of death versus dulaglutide 1 This study is the first to directly compare these glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications in everyday real-life use. It fills a significant gap in...
Nasdaq GlobeNewswire
18/09/2025
inne Debuts at expopharm 2025: Delivering Scientific Nutrition to Support Global…
"Our mission is to lay a foundation of lifelong health for children worldwide," said Daniela, Director of Marketing at inne Germany. "Our presence at expopharm is a comprehensive demonstration of our scientific nutrition system." "Our mission is to lay a foundation of lifelong health for children worldwide," said Daniela, Director of Marketing at inneGermany. "Our presence at expopharm is a comprehensive demonstration of our scientific nutrition system."…
PR Newswire
18/09/2025
Concurrent Publications in Nature and Nature Medicine Highlight Advances in…
Detailed results from clinical feasibility studies show immediate improvement in blood pressure stability and durable reduction of hypotensive symptoms, resulting in improved quality of lifeMost people living with spinal cord injury experience blood pressure instability, which represents a key unmet needToday’s concurrent publications provide clinical evidence for ARC-IM ® Therapy ahead of the Company’s planned initiation of the Empower BP global pivotal trial later this year ...
Nasdaq GlobeNewswire
18/09/2025
Roche enters into a definitive merger agreement to acquire 89bio, and its phase…
89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe Metabolic Dysfunction-Associated Steatohepatitis (MASH), one of the most prevalent comorbidities of obesityAcquisition supports Roche’s strategy as it enhances the company’s portfolio in cardiovascular, renal, and metabolic diseases (CVRM) and offers optionality for future combination developmentRoche to acquire 89bio for US$14.50 per share in cash at closing, representing a total equity...
Nasdaq GlobeNewswire
18/09/2025
Science Based Targets initiative (SBTi) validates EUROAPI’s near-term climate…
Press Release 42% reduction in Scope 1 and 2 Greenhouse Gas emissions by 2030 (vs. 2022)25% reduction in Scope 3 GHG emissions by 2030 (vs. 2022)September 18, 2025 -EUROAPI’s near-term science-based emission reduction targets have been approved by the Science Based Targets initiative (SBTi 1 ), confirming the company’s alignment with the Paris Agreement trajectory of limiting global warming to 1.5°C above pre-industrial levels. EUROAPI commits to reduce absolute...
Nasdaq GlobeNewswire
18/09/2025
Rockefeller Foundation's New US $50 Million Initiative Finds Widespread Support…
Global Cooperation SurveyAt a moment of massive global disruption, including dramatic cuts to humanitarian and development work—for example, the Organization for Economic Cooperation and Development (OECD) has predicted official development assistance (ODA) to fall by an additional 9%-17% this year—The Rockefeller Foundation's new survey captures how people view global cooperation and key international institutions. Conducted between August 8 to September 10, 36,405 adults spanning various age…
PR Newswire
18/09/2025
EssilorLuxottica: EssilorLuxottica and Meta build on their successful…
EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the futureThe two companies continue to grow their wearables lineup with new products revealed at Meta ConnectParis, France and Menlo Park, California (18 September 2025)– EssilorLuxottica and Meta Platforms, Inc. showcased the evolution of their celebrated partnership at Meta Connect, where they unveiled the next generation of AI glasses. Expanding on the groundbreaking...
Nasdaq GlobeNewswire
18/09/2025
EADV Congress 2025: GLP-1RA drugs dramatically reduce death and cardiovascular…
Psoriasis is a chronic skin condition affecting 2-3% of the population, linked not only to visible symptoms but also to higher risks of heart attack, stroke and psychiatric issues, including depression, anxiety and increased alcohol or substance use. GLP-1RAs, including semaglutide and liraglutide, are widely used to treat type 2 diabetes and obesity. However, this emerging evidence suggests they may also offer important benefits for psoriasis patients. Psoriasis is a chronic skin condition...
PR Newswire
18/09/2025
Interleukin-13 Inhibitors Market Predicted to Surge During the Forecast Period…
Key Takeaways from the Interleukin-13 Inhibitors Market Report Key Takeaways from the Interleukin-13 Inhibitors Market Report Discover which indication is expected to grab the major interleukin-13 inhibitors market share @Interleukin-13 Inhibitors Market Report Key Factors Driving the Interleukin-13 Inhibitors Market Domination of DUPIXENT in the IL-13 market DUPIXENT (dupilumab), a blockbuster biologic developed by Sanofi and Regeneron, currently dominates the market...
PR Newswire
17/09/2025
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6%…
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy ® ) achieved significant weight loss, with one in three study participants losing 20% or more body weight 1** Oral semaglutide 25 mg also demonstrated improvements in the ability to perform everyday physical activities such as bending, standing, walking, being physically active, and improvements in cardiovascular risk factors 1 Oral semaglutide 25 mg is the first oral GLP-1 therapy submitted to the US Food and Drug...
Nasdaq GlobeNewswire
17/09/2025
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the…
Postpartum depression is a leading cause of maternal mortality in Europe 1-2, and is one of the most common medical conditions associated with pregnancy 3-5 ; up to 20% of women experience postpartum depressive symptoms 6-11 The approval of this new therapeutic approach introduces an oral, 14-day treatment specifically indicated for PPDThe EC approval of ZURZUVAE is based on the SKYLARK study, which demonstrated rapid relief from depressive symptoms as early as day 3 and sustained...
Nasdaq GlobeNewswire
17/09/2025
SAM Medical expands emergency medical offering with strategic acquisition of…
"The acquisition of TyTek Medical strengthens our ability to deliver a comprehensive range of solutions for emergency medical professionals," said Jim Seidel, CEO of SAM Medical. "TyTek's strong reputation for high-quality, life-saving products aligns perfectly with our commitment to support first responders in their most critical moments. This acquisition better positions us to set the standard in the markets we serve." "The acquisition of TyTek Medical strengthens our…
PR Newswire
17/09/2025
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900…
Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple prior lines of therapy including anti-PD-1Recommended phase 2 dose (RP2D) established at 33% of gross tumor volume (GTV)47.4% (9/19) best observed objective response rate (ORR) in all lesions per RECIST 1.178.9% (15/19) best observed disease control rate (DCR) in all lesions per RECIST 1.114.6 months median Overall Survival (mOS) in all patients...
Nasdaq GlobeNewswire
17/09/2025
Altri Comunicati
